Jeffrey Sevigny

Insider Reports History

Entity
Individual
Location
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, New York
Signature
/s/ Katherine Denby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey Sevigny:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. Director Stock Option (right to buy) 25K Jun 15, 2022 Direct

Insider Reports Filed by Jeffrey Sevigny

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABOS Acumen Pharmaceuticals, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 Director